A detailed history of Keudell transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Keudell holds 33,450 shares of CNTB stock, worth $33,450. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,450
Previous 32,200 3.88%
Holding current value
$33,450
Previous $48,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$0.99 - $1.6 $1,237 - $2,000
1,250 Added 3.88%
33,450 $48,000
Q2 2024

Jul 16, 2024

BUY
$1.28 - $2.2 $16,000 - $27,500
12,500 Added 63.45%
32,200 $48,000
Q1 2024

May 07, 2024

BUY
$1.01 - $1.74 $8,585 - $14,790
8,500 Added 75.89%
19,700 $34,000
Q4 2023

Feb 14, 2024

BUY
$0.7 - $2.06 $7,839 - $23,072
11,200 New
11,200 $13,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.